Another interesting study utilizing a gel-based proteomic approach showed decreased spot intensity (up to 70–90%) of SIP (Siah-interacting protein) in the Cur-treated (Cur sensitive) compared to the Cur-resistant human acute lymphocytic leukemia (MOLT-4) cells that caught the attention of the researchers. The gene discussed is CACYBP; the disease is acute lymphoblastic leukemia.